DBVT
DBV Technologies S.A.
NASDAQ · Healthcare · Biotechnology · FR
$13.47
−1.68%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-109.6%
Return on equity
-78.8%
Return on assets
-99.9%
Return on invested capital
0.00x
Asset turnover
-$199.8M
Cash from operations
$2.78
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026